Article
Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.
Epigenetics - 1 Jul 2012
Brait Mariana, Loyo Myriam, Rosenbaum Eli, Ostrow Kimberly L, Markova Alina, Papagerakis Silvana, Zahurak Marianna, Goodman Steven M, Zeiger Martha, Sidransky David, Umbricht Christopher B, Hoque Mohammad O
Abstract excerpt
Our aim was to comprehensively analyze promoter hypermethylation of a panel of novel and known methylation markers for thyroid neoplasms and to establish their relationship with BRAF mutation and clinicopathologic parameters of thyroid cancer. A cohort of thyroid tumors, consisting of 44 cancers and 44 benign thyroid lesions, as well as 15 samples of adjacent normal thyroid tissue, was evaluated for BRAF mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
